Search
Close this search box.
Logo Asphalion

WEBINAR RECORDING | Clinical Trials transition to CTR/CTIS

May 27, 2024

Watch Asphalion expert Nuria García as she goes over transition timelines and procedures, how to prepare a transition application and how to manage post- transition actions.

We would like to thank everyone for the interest shown in our webinars and we look forward to sharing much more knowledge and experience with our audience.

You can now watch the “Clinical Trials transition to CTR/CTIS” Webinar here:

CLINICAL TRIALS TRANSITION TO CTR/CTIS

For further information, please feel free to contact us at: [email protected]

Search News & Events

  • Filter by category

Share

Related news and events

NEWS | Important Update from the FDA!

This guidance recommends steps manufacturers and applicants of active pharmaceutical ingredients (APIs) and drug products should take to detect and prevent unacceptable levels of nitrosamine impurities in drug products. The guidance also describes conditions that may introduce nitrosamine impurities. The unexpected finding of nitrosamine impurities, which are probable or possible human carcinogens, in certain drug products has made clear the need for a risk assessment strategy for the potential presence of nitrosamines in any drug product.

For further information

If you are interested in our services, or wish to get in touch for a general enquiry, please contact us for more information.

Fill the form and we will contact you as soon as possible.

You can also follow us on:

Schedule a Free Meeting

Schedule here a free 30-minutes meeting with one of our consultants and tell us about your project, challenges or doubts. 

We will be happy to assist you!

Schedule a meeting